Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 161205, 8 pages
http://dx.doi.org/10.1155/2012/161205
Research Article

Antilithiasic and Hypolipidaemic Effects of Raphanus sativus L. var. niger on Mice Fed with a Lithogenic Diet

1Facultad de Química Farmacéutica Biológica, Universidad Veracruzana, Xalapa, Veracruz, Mexico
2Laboratorio de Neurofarmacología, Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, México, DF, Mexico
3Laboratorio de Productos Naturales, Instituto de Ciencias Básicas, Universidad Veracruzana, Xalapa, Veracruz, Mexico

Received 22 June 2012; Revised 13 September 2012; Accepted 14 September 2012

Academic Editor: Ayman El-Kadi

Copyright © 2012 Ibrahim Guillermo Castro-Torres et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Portincasa, A. Moschetta, and G. Palasciano, “Cholesterol gallstone disease,” Lancet, vol. 368, no. 9531, pp. 230–239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. C. E. Ruhl and J. E. Everhart, “Gallstone disease is associated with increased mortality in the United States,” Gastroenterology, vol. 140, no. 2, pp. 508–516, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Méndez-Sánchez, J. Bahena-Aponte, N. C. Chávez-Tapia et al., “Strong association between gallstones and cardiovascular disease,” American Journal of Gastroenterology, vol. 100, no. 4, pp. 827–830, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Di Ciaula, D. Q. H. Wang, H. H. Wang, L. Bonfrate, and P. Portincasa, “Targets for current pharmacologic therapy in cholesterol gallstone disease,” Gastroenterology Clinics of North America, vol. 39, no. 2, pp. 245–264, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. K. J. Maurer, M. C. Carey, and J. G. Fox, “Roles of infection, inflammation, and the immune system in cholesterol gallstone formation,” Gastroenterology, vol. 136, no. 2, pp. 425–440, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. C. S. Stokes, M. Krawczyk, and F. Lammert, “Gallstones: environment, lifestyle and genes,” Digestive Diseases, vol. 29, no. 2, pp. 191–201, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. K. J. Van Erpecum, “Pathogenesis of cholesterol and pigment gallstones: an update,” Clinics and Research in Hepatology and Gastroenterology, vol. 35, no. 4, pp. 281–287, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. C. Vázquez, A. Rigotti, and S. Zanlungo, “Molecular mechanisms underlying the link between nuclear receptor function and cholesterol gallstone formation,” Journal of Lipids, vol. 2012, Article ID 547643, 7 pages, 2012. View at Publisher · View at Google Scholar
  9. I. G. Castro-Torres, “Cholesterol gallstones formation: new scientific advances,” Revista GEN (Gastroenterología Nacional), vol. 66, no. 1, pp. 57–62, 2012. View at Google Scholar
  10. A. H. M. Smelt, “Triglycerides and gallstone formation,” Clinica Chimica Acta, vol. 411, no. 21-22, pp. 1625–1631, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. O. de Bari, B.A. Neuschwander-Tetri, M. Liu M et al., “Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic fatty liver disease,” Journal of Lipids, vol. 2012, Article ID 302847, 16 pages, 2012. View at Publisher · View at Google Scholar
  12. A. Lugasi, A. Blázovics, K. Hagymási, I. Kocsis, and Á. Kéry, “Antioxidant effect of squeezed juice from black radish (Raphanus sativus L. var niger) in alimentary hyperlipidaemia in rats,” Phytotherapy Research, vol. 19, no. 7, pp. 587–591, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Vargas, R. M. Perez, S. Perez, M. A. Zavala, and C. Perez, “Antiurolithiatic activity of Raphanus sativus aqueous extract on rats,” Journal of Ethnopharmacology, vol. 68, no. 1–3, pp. 335–338, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. P. R. Hanlon, M. G. Robbins, L. D. Hammon, and D. M. Barnes, “Aqueous extract from the vegetative portion of Spanish black radish (Raphanus sativus L. var. niger) induces detoxification enzyme expression in HepG2 cells,” Journal of Functional Foods, vol. 1, no. 4, pp. 356–365, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. P. R. Hanlon, D. M. Webber, and D. M. Barnes, “Aqueous extract from Spanish black radish (Raphanus sativus L. var. niger) induces detoxification enzymes in the HepG2 human hepatoma cell line,” Journal of Agricultural and Food Chemistry, vol. 55, no. 16, pp. 6439–6446, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. I. G. Castro-Torres and E. B. Naranjo-Rodríguez, “Treatment with black radish (Raphanus Sativus L. var niger) reduces serum lipids levels in mice fed with a lithogenic diet,” Revista Latinoamericana de Quimica, vol. 39, no. 3, p. 273, 2012. View at Google Scholar
  17. E. Reihnér and D. Ståhlberg, “Lithogenic diet and gallstone formation in mice: integrated response of activities of regulatory enzymes in hepatic cholesterol metabolism,” British Journal of Nutrition, vol. 76, no. 5, pp. 765–772, 1996. View at Google Scholar · View at Scopus
  18. A. Lugasi, A. Blázovics, K. Hagymási et al., “Antioxidant and free radical scavenging properties of squeezed juice from black radish (Raphanus sativus L. var niger) root,” Phytotherapy Research, vol. 12, pp. 502–506, 1998. View at Google Scholar
  19. L. N. Rodríguez-Cantú, J. A. Gutiérrez-Uribe, J. Arriola-Vucovich, R. I. Díaz-De La Garza, J. W. Fahey, and S. O. Serna-Saldivar, “Broccoli (brassica oleracea var. italica) sprouts and extracts rich in glucosinolates and isothiocyanates affect cholesterol metabolism and genes involved in lipid homeostasis in hamsters,” Journal of Agricultural and Food Chemistry, vol. 59, no. 4, pp. 1095–1103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. R. L. Lipnick, J. A. Cotruvo, R. N. Hill et al., “Comparison of the up-and-down, conventional LD50, and fixed-dose acute toxicity procedures,” Food and Chemical Toxicology, vol. 33, no. 3, pp. 223–231, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Ebihara and S. Kiriyama, “Prevention of cholesterol gallstones by a water-soluble dietary fiber, konjac mannan, in mice,” Nutrition Reports International, vol. 32, no. 1, pp. 223–229, 1985. View at Google Scholar · View at Scopus
  22. P. Portincasa, A. Di Ciaula, H. H. Wang, A. Moschetta, and D. Q. H. Wang, “Medicinal treatments of cholesterol gallstones: old, current and new perspectives,” Current Medicinal Chemistry, vol. 16, no. 12, pp. 1531–1542, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Boehler, M. Riottot, J. Férézou et al., “Antilithiasic effect of β-cyclodextrin in LPN hamster: comparison with cholestyramine,” Journal of Lipid Research, vol. 40, no. 4, pp. 726–734, 1999. View at Google Scholar · View at Scopus
  24. D. E. Hansel, A. Maitra, and P. Argani, “Pathology of the gallbladder: a concise review,” Current Diagnostic Pathology, vol. 10, no. 4, pp. 304–317, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Q. Wang, D. E. Cohen, and M. C. Carey, “Biliary lipids and cholesterol gallstone disease,” Journal of Lipid Research, vol. 50, supplement, pp. S406–S411, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. V. I. Reshetnyak, “Concept of the pathogenesis and treatment of cholelithiasis,” World Journal of Hepatology, vol. 4, no. 2, pp. 18–34, 2012. View at Google Scholar